- Filed
- May 11, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 6, 2026 | 48.17M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 48.33M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 48.15M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $404K |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $0 |
| Capex | Q1 2026 · Mar 31, 2026 | $11.71M |
| Capex restated | Q1 2026 · Mar 31, 2025 | $462K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$3.03M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $2.71M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $92.72M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $101.99M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $262.95M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $258.29M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $252.51M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $252.82M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $75.27M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $70.02M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $81.79M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $76.61M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $184.79M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $177.15M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $344.74M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $334.89M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.11 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.01 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.11 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.01 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $3.6M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $4.12M |
| Net Income | Q1 2026 · Mar 31, 2026 | $5.19M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$537K |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$869K |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$1.16M |
| Revenue | Q1 2026 · Mar 31, 2026 | $22.03M |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $11.63M |